Litcius/Paper detail

TYK2: an emerging therapeutic target in rheumatic disease

Eric F. Morand, Joseph F. Merola, Yoshiya Tanaka, Dafna D. Gladman, Roy Fleischmann

2024Nature Reviews Rheumatology53 citationsDOI

Topics & Concepts

Tyrosine kinase 2Janus kinaseMedicinePsoriasisImmunologyImmune systemJanus kinase 1Tyrosine kinaseDermatomyositisCancer researchCytokineReceptorInternal medicinePlatelet-derived growth factor receptorGrowth factorCytokine Signaling Pathways and InteractionsRheumatoid Arthritis Research and TherapiesSystemic Lupus Erythematosus Research
TYK2: an emerging therapeutic target in rheumatic disease | Litcius